Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

July 24, 2025

Study Completion Date

July 24, 2025

Conditions
Atrophic Scar
Interventions
DEVICE

Subjects treated with Newest medical device

"Newest is a sterile, non-pyrogenic, viscoelastic gel for single use for intradermal infiltrations. Newest is a medical device containing 2ml of the original association of polynucleotides (10mg/ml) and hyaluronic acid (10mg/ml).~Total number of treatments will consist in 4 Newest administrations: at T0 - basal, at T1- 2 weeks, at T2 - 4 weeks, at T3- 6 weeks."

Trial Locations (1)

Unknown

Fatebenefratelli Hospital, Roma

All Listed Sponsors
lead

Mastelli S.r.l

INDUSTRY

NCT05936437 - Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment | Biotech Hunter | Biotech Hunter